Puma Biotechnology (PBYI) Shares Outstanding (2010 - 2026)

Puma Biotechnology (PBYI) has 16 years of Shares Outstanding (Entity) data on file, last reported at $50.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.55% year-over-year to $50.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.9 million (up 2.55% YoY) and the FY2025 annual result came in at $50.4 million, up 2.65% from the prior year.
• Shares Outstanding (Entity) rose to $50.9 million in Q1 2026, from $50.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $50.9 million in Q1 2026 to a low of $44.9 million in Q1 2022.
• A 5-year average of $48.1 million and a median of $48.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 12.56% — and 2026, when it climbed 2.55%.
• Tracing PBYI's Shares Outstanding (Entity) over 5 years: stood at $46.3 million in 2022, then climbed by 2.81% to $47.6 million in 2023, then gained by 3.06% to $49.1 million in 2024, then grew by 2.65% to $50.4 million in 2025, then rose by 0.93% to $50.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $50.9 million (Q1 2026), $50.4 million (Q4 2025), and $50.4 million (Q3 2025), per Business Quant data.